Let’s just watch from the sidelines for now. If you had 100,000 shares last Friday, you now own 500 shares. Opened at $6.50 ($0.03 pre-split), and opened at $4.25 ($0.02) today.
As of 9/30/22 they had $7.3 million in cash, and 3.3 million shares outstanding. Sales for the trailing 12 months were $40 million. Hmm.
$10 Million Securities Purchase Agreement with NextPlat Corp (NXLP).
Charles M. Fernandez as New Chief Executive Officer
Good story fundamentally. We’d imagine an attempt at a financing should be in the offing.
Progressive Care, Inc. Announces Reverse Stock Split and Will Trade Under Temporary Symbol RXMDD
Miami, FL, Dec. 30, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Progressive Care Inc. (OTCQB: RXMD and RXMDD):
Open web version
Progressive Care Inc. (OTCQB: RXMD and RXMDD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, announced today that its Board of Directors approved a 1-for-200 reverse stock split of its common stock shares and that the common stock shares will begin trading on a split-adjusted basis at the commencement of trading on December 30, 2022. The common stock shares will trade on the OTCQB markets under the symbol “RXMDD”. After 20 days, the symbol will revert to “RXMD”. The Board of Directors also approved a change in the authorized common stock shares from one billion (1,000,000,000) to one hundred million (100,000,000) common stock shares.
“We are pleased to announce this reverse stock split as we believe it is in the best interest of our shareholders and will help Progressive Care to attract institutional investors as we continue to grow. The reverse stock split changes the price per share and number of shares outstanding but has no effect on the operations of our company nor its size and growth potential,” stated Charles M. Fernandez, Chief Executive Officer of Progressive Care, Inc.
At the commencement of trading on December 30, every two hundred shares of the Company’s issued and outstanding common stock shares will be automatically converted into one issued and outstanding common stock share.
Stockholders holding shares through a brokerage account will have their shares automatically adjusted to reflect the 1-for-200 reverse stock split and do not need to take any action in connection with the reverse stock split. It is not necessary for stockholders holding shares in certificate form to exchange their existing stock certificates for new stock certificates of the Company in connection with the reverse stock split, although stockholders may do so if they wish.
The reverse stock split will affect all stockholders uniformly and will not alter any stockholder’s percentage interest in Progressive Care’s equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share. No fractional shares will be issued in connection with the reverse stock split. Any fractional share of a stockholder resulting from the reverse stock split will be rounded up to the nearest whole common stock share.
Proportional adjustments will be made to the number of common stock shares issuable upon exercise or conversion of Progressive Care’s outstanding equity awards, warrants or other convertible securities, as well as the applicable exercise or conversion price. Stockholders whose shares are held in brokerage accounts should direct any questions concerning the reverse stock split to their broker. All stockholders of record, holding their shares in certificated form, may direct questions to the Company’s transfer agent, ClearTrust, LLC, at 16540 Pointe Village Dr., Suite 205, Lutz, FL 33558.
For more information about Progressive Care, please visit the Company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
Progressivecareus.com
PharmcoRx Pharmacy
Pharmcorx.com
ClearmetrX
Clearmetrx.com
About Progressive Care
Progressive Care Inc. (OTCQB: RXMD and RXMDD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding departure of the company’s CEO. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
[email protected]
